Five trends happening in the laboratory industry - Insights
Managing a successful hospital-based laboratory in today’s economic climate requires leaders to anticipate challenges, navigate obstacles, and develop creative approaches to unusual circumstances. The Mayo Clinic Laboratories outreach team...
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Mayo Clinic Laboratory and pathology research roundup: January 11 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to...
As a global reference laboratory integrated with a world-renowned academic health care institution, Mayo Clinic Laboratories helps providers advance patient care, strengthen your practice, and broaden access to specialized testing. Follow...
Mayo Clinic Laboratories works with hospitals and health care institutions to strengthen their ability to reach more patients and provide the best possible outcomes. These case studies feature some of challenges that Mayo Clinic...
Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and
September 2020 — Clinical Microbiology, Hematology, Hematopathology, & Infectious Disease - Insights
This "Pathways" program provides a Anatomic and Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology, Hematology, Hematopathology, and...
Pathways Case Studies: March 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Bone and Soft Tissue, Clinical...
March 2023 - Breast Pathology Case 1 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
Pathways Case Studies: September 2019 - Insights
Mayo Clinic laboratory experts share five case studies in this month’s “PathWays” post and are challenging you to test your laboratory genetics & genomics, bone & soft tissue, renal, infectious disease, and gastroenterology pathology...
Short recordings surrounding disease diagnosis through new methods in testing and treatment.
A Test in Focus Archives - Page 10 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn more about our pediatric oncology testing, which was carefully developed by a team of experts to provide efficient, actionable answers.
Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.
Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
Subspecialty testing - Insights
Check out Mayo Clinic Laboratories’ comprehensive selection of pathology testing, which can guide diagnosis of malignancies and other diseases.
July 2023 - Molecular Pathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Molecular Pathology.
Malabsorption - Mayo Clinic Laboratories
Stool testing is a critical component of diagnosing EPI and Mayo Clinic Laboratories offers multiple tests to help clinicians in their work-up of these patients.
Diagnosis and inflammation monitoring - Insights
Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.
Learn more about how Mayo Clinic Laboratories’ genetic testing for pulmonary conditions can provide diagnostic confirmation for an array of inherited illnesses.
Exploratory testing - Insights
Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.
Learn more about how immunology testing at Mayo Clinic Laboratories can reveal genetic associations to disorders that impact the immune system.
Mucopolysaccharidosis - Insights
Learn more about how Mayo Clinic Laboratories’ testing for mucopolysaccharidosis can assist with diagnosis and disease management.
Learn more about how Mayo Clinic Laboratories’ unique testing for sphingolipidoses, including Gaucher and Krabbe diseases, can confirm diagnosis and guide disease management.
Research collaborations - Insights
Find out about setting up a contract with Mayo Clinic, analytical validation, the role of the institutional review board, and how your data will be handled.
Invasive fungal infection - Insights
Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.
Histoplasma/Blastomyces - Insights
Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.
Ova and parasite testing - Insights
Learn about our ova and parasite test and its role as a fundamental laboratory method to detect parasitic helminths and protozoa in stool specimens.
Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.
Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.
Thiopurine Management Testing for IBD - Mayo Clinic Laboratories
Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Genetic liver disease - Insights
Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...
For children who require thiopurine medications (such as azathioprine and 6-mercaptopurine) to treat inflammatory bowel disease (IBD), understanding how thiopurines are metabolized is vital to choosing the most effective treatment. Because...
Viral Hepatitis Testing - Mayo Clinic Laboratories
At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Neurodevelopmental disorders - Insights
Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.
Comprehensive urine drug profiles - Insights
Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Chain of custody drug testing - Insights
Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.
Comprehensive drug urine profiles - Insights
Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Find out how our kidney stone services identify the physical compositions of stones to help optimize care for patients with nephrolithiasis.
Urine supersaturation testing - Insights
Find out how our kidney stone testing services can predict the likely composition of stones in patients for whom stone analysis is not available.
Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.
Skip to Content MayoACCESS MayoLINK...
Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D. - Insights
Anne Tebo, Ph.D., explains how Mayo Clinic Laboratories' new serum tests help overcome the challenges of diagnosing primary biliary cholangitis, or PBC. Test results can guide clinical care for patients with this life-threatening autoimmune...
Chromosomal microarray better informs brain tumor diagnosis - Insights
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...